Lesões faciais por osteodistrofia renal em paciente com insuficiência renal crônica: relato de caso by Karsburg, Rafael Machado et al.
  Universidade de São Paulo
 
2012
 
Facial lesions caused by renal osteodystrophy
in a patient with chronic renal insufficiency: a
case report
 
 
Rev. odonto ciênc.,v.27,n.2,p.161-165,2012
http://www.producao.usp.br/handle/BDPI/40558
 
Downloaded from: Biblioteca Digital da Produção Intelectual - BDPI, Universidade de São Paulo
Biblioteca Digital da Produção Intelectual - BDPI
Departamento de Estomatologia - FO/ODE Artigos e Materiais de Revistas Científicas - FO/ODE
 Rev Odonto Cienc 2012;27(2):161-165 161
Received: July 21, 2011
Accepted: April 10, 2012
Conflict of Interests: The authors state that there 
are no financial and personal conflicts of interest that 
could have inappropriately influenced their work. 
Copyright: © 2011 Karsburg et al.; licensee 
EDIPUCRS. This is an Open Access article distributed 
under the terms of the Creative Commons Attribution-
Noncommercial-No Derivative Works 3.0 Unported 
License.
Case Report
Facial lesions caused by renal osteodystrophy 
in a patient with chronic renal insufficiency: 
A case report
Lesões faciais por osteodistrofia renal em paciente com 
insuficiência renal crônica: Relato de caso
Rafael Machado Karsburg a 
Kátia Regina de Campos b 
Maria Paula de Siqueira Melo Peres c 
Sheyla Batista Bologna d 
Silvia Vanessa Lourenço e 
Juliana Bertoldi Franco f
a Residência em Odontologia Hospitalar, Hospital 
das Clínicas da Faculdade de Medicina da 
Universidade de São Paulo (HCFMUSP), São 
Paulo, SP, Brasil
b Curso de aprimoramento em Odontologia 
Hospitalar, HCFMUSP, São Paulo, SP, Brasil
c Divisão de Odontologia do Instituto Central do 
HCFMUSP, São Paulo, SP, Brasil
d Curso de Doutorado em Ciências da Saúde, 
Disciplina de Dermatologia, HCFMUSP, São Paulo, 
SP, Brasil
e Disciplina de Patologia Geral, Faculdade de 
Odontologia, Universidade de São Paulo, São 
Paulo, SP, Brasil
f Serviço de Odontologia do Hospital Auxiliar de 
Suzano do HCFMUSP, São Paulo, SP, Brasil
Correspondence:
Juliana Bertoldi Franco 
Av. Dr. Eneas de Carvalho Aguiar, 155 
(PAMB, 6 andar, sala 02)
Divisão de Odontologia do Instituto Central do 
HCFMUSP
São Paulo, SP – Brasil  
05403-900 
E-mail: juliana.franco@hc.fm.usp.br
Abstract
Purpose: Chronic renal insufficiency (CRI) is the last stage of a chronic renal condition in which 
the kidney loses its filtration and endocrine functions. Chronic endocrine hypofunction causes 
generalized damage to the body known as Uremic Syndrome, which affects the central nervous 
system as well as the cardiovascular, hematologic, dermatologic, ophthalmic, endocrine, 
respiratory, gastrointestinal and skeletal systems. The present study reports the case of a female 
patient with CRI who presented facial osteodystrophy of the osteitis fibrosa type, and highlights 
the main features of this condition. 
Case Description: A 24-year old, female, Caucasian patient presented chronic glomerulonephritis 
recurrence and lost the transplanted kidney five years before, undergoing arteriovenous fistula 
hemodialysis three times a week. She presented swelling of the left masseter area with a hard 
consistency on palpation, covered by intact skin, swelling at the bottom of the left atrium, 
with a hard consistency on palpation, a mucosa-like color and absence of inflammation 
signs, suggesting expansive bone lesions on the face. These features were compatible with 
hyperparathyroidism brown tumor and/or osteodystrophy. The CT scan showed expansive 
bone lesions of heterogeneous appearance on the left jaw, maxilla/nasal floor, and right 
frontotemporal suture areas. The clinical and histopathological characteristics of the lesion, 
in association with PHT hormone high serum levels led to renal osteodystrophy diagnosis. The 
patient was referred to the nephrology services. 
Conclusion: Osteodystrophic bone alterations have a high prevalence in renal disease patients, 
and the dentist must take these alterations into consideration in bone lesion diagnosis for this 
specific group of patients.
Key words: Chronic renal insufficiency; renal dialysis; renal osteodystrophy
Resumo
Objetivo: A Insuficiência Renal Crônica (IRC) é o último estágio da doença renal crônica, 
na qual o rim perde sua função de filtração e endócrina. A hipofunção endócrina renal 
ocasiona danos generalizados ao organismo, que no conjunto são conhecidos como Síndrome 
Urêmica, sendo composta por danos que comprometem o sistema nervoso central, assim 
como os sistemas cardiovasculares, hematológicos, dermatológicos, oftálmicos, endócrinos, 
respiratórios, gastrointestinais e ósseos. O presente estudo irá relatar o caso de uma paciente 
portadora de IRC apresentando osteodistrofia em face do tipo osteíte fibrosa, evidenciando 
as principais características dessa doença. 
Descrição do caso: Uma paciente de 24 anos, sexo feminino, caucasiana, apresentou 
glomerulonefrite recorrente após perda do rim transplantado, estando sob hemodiálise três 
vezes por semana. Apresentou inchaço da área do m. masseter esquerdo com consistência dura 
à palpação, coberto por pelo de aspecto normal, inchaço do átrio esquerdo, com consistência 
dura e ausência de sinais inflamatórios, sugerindo lesões ósseas na face. Estas características 
eram compatíveis com tumor marrom de hiperparatireoidismo e/ou osteodistrofia. A imagem 
de tomografia computadorizada mostrou lesões ósseas expansivas de aparência heterogênea 
na mandíbula esquerda, assoalho da maxila e nasal, e nas áreas de sutura frontotemporal 
direita. As características clínicas e histopatológicas da lesão, em associação com níveis séricos 
elevados de hormônio PHT conduziram ao diagnóstico de osteodistrofia renal. A paciente foi 
encaminhada para o serviço de nefrologia. 
Conclusão: As alterações ósseas osteodistróficas são de grande prevalência em pessoas com 
doença renal, tendo o cirurgião-dentista o dever de levá-las em consideração no diagnóstico 
de lesões ósseas neste grupo específico de pessoas.
Palavras-chave: Insuficiência renal crônica; diálise renal; osteodistrofia renal
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Introdução
The kidneys regulate different systems in the human 
body, being responsible for body metabolite excretion, 
electrolyte balance and arterial blood pressure regulation, 
red blood cell secretion, gluco-neogenesis, and vitamin D 
production (1). 
The final kidney disease stage is called Chronic Renal 
Insufficiency (CRI), which is characterized by extensive 
damage as well as a progressive and irreversible loss of 
the kidney glomerular, tubular and endocrine functions. 
A reduced or absent function of the kidneys can lead to 
alterations in the function of other body systems, known as 
Uremic Syndrome. Major uremic syndrome manifestations 
include central and peripheral neurological damage, 
as well as cardiovascular, skin, ophthalmic, endocrine, 
gastrointestinal and bone damage (2-4). 
The kidneys play an important role in bone metabolism 
due to their participation in vitamin D synthesis. The 1,25- 
dihydroxyvitamin D3, or simply vitamin D, in association 
with other hormones and minerals, is responsible for 
mediating the intestinal absorption of calcium, which 
influences plasma calcium levels and bone metabolism (1). 
When the endocrine function of the kidneys has been 
impaired, there occurs a decrease in vitamin D production, 
leading to a reduction in dietary calcium absorption, thus 
decreasing the availability of this mineral in the blood. 
This hypocalcemia will compensatorily increase the 
parathyroid hormone (PTH) serum levels, characterizing 
a secondary hyperparathyroidism condition to CRI. 
This hyperparathyroidism, if left untreated, can trigger 
characteristic bone lesions known as renal osteodys- 
trophy (3).
Renal osteodystrophy is defined as a skeletal change 
showing specific characteristics whose etiology is related 
to hormonal deregulation in the uremic syndrome, which 
interferes with bone apposition and resorption in the patient 
with CRI, and can affect up to 50% of the patients with 
end-stage renal disease (ESRD) (5). Facial skeleton lesions 
are the first symptoms in most cases (6). Osteodystrophy 
can be divided into three groups: high remodeling bone 
disease, low remodeling bone disease, and an in-between 
group (Table 1) (5,7).
The present study aims to report a case of a patient 
with CRI who developed the high remodeling facial 
osteodystrophy type (osteitis fibrosa) and to discuss the 
main features of the disease, as well as its associations with 
bone pathologies.
Case Report
A 24-year old, female, Caucasian patient with ESRD 
caused by glomerulonephritis, on a kidney transplant waiting 
list and undergoing dialysis was referred to the Dentistry 
Division of the Central Institute at the Clinics Hospital of 
the Medicine School of São Paulo University complaining 
about odontalgia in the left mandibular area.
At the interview, the patient reported having been 
submitted to kidney transplantation eleven years before; 
however, due to chronic glomerulonephritis recurrence, she 
lost the transplanted kidney five years before. So she needed 
to undergo arteriovenous fistula hemodialysis three times 
a week. The patient denied having any bad habits, drug 
allergies, diabetes, or other relevant systemic comorbidities, 
and mentioned the use of the following medications: 
calcium phosphate, sodium fluoride, nifedipine, sevelamer 
hydrochloride, omeprazole and erythropoietin.
Upon extra-oral examination, a swelling of the left 
masseter area showing a hard consistency on palpation, 
and covered with intact skin, was observed. Upon intra-oral 
examination, tooth 36, showing extensive carious lesions and 
pulpal involvement, was identified as the source of the pain 
reported by the patient; in addition, a swelling at the bottom 
of the left atrium, with a hard consistency on palpation, a 
mucosa-like color and the absence of inflammation signs, 
suggestive of the presence of expansive bone lesions on the 
face and compatible with hyperparathyroidism brown tumor 
and/or osteodystrophy, was found. The patient also presented 
mild generalized periodontitis in tooth-supporting tissues.
A CT scan and blood tests (blood count and coagulation 
profile with platelet count) were asked so that surgical 
removal and local biopsy could be performed.
The CT scan identified expansive bone lesions of hetero- 
geneous appearance on the left jaw (Fig. 1 and Fig. 2), maxilla/
nasal floor (Fig. 3 and fig. 4), and right frontotemporal suture 
(Fig. 5 and Fig. 6) areas.
The patient underwent lower left first molar extraction 
with antibiotics prophylaxis as prescribed by the American 
Heart Association (2 g amoxicillin 1 hour before procedure), 
since she was being submitted to arteriovenous fistula dialysis. 
During surgery, bone fragments from the tooth socket were 
collected for pathology. The microscopic aspect excluded 
brown tumor occurrence, and described numerous bone 
trabeculae surrounded by connective tissue rich in fibroblasts.
Table 1. Renal osteodystrophy lesions and their characteristics (3)
Group Subtype Characteristics
H
ig
h 
re
m
od
el
in
g
Osteitis Fibrosa
PHT increase due to hypocalcemia/ 
hyperphosphatemia, intense 
osteoblastic and clastic activity, 
fibrous cord lesions and normal or 
increased mineralization
In
te
rm
ed
ia
te
Mixed disease An association of two osteodystrophic entities
Lo
w
 r
em
od
el
in
g
Osteomalacia
Accumulation of non-mineralized 
osteoid matrix due to hipocalcemia/
hypo-phosphatemia, reduction 
in vitamin D production or bone 
toxicity by aluminum
Aplastic or adynamic 
bone disease 
Reduction in osteoid secretion and 
thickness of unknown etiology
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Fig. 7. Histological image of 
the lesion composed of dense 
connective tissue permeated by 
inflammatory cells and hemosiderin 
pigments. There is no presence of 
multinucleated giant cells. (optical 
microscopy , 40x zoom, HE).
Fig. 1. Three-dimensional 
reconstruction in CT scan: an 
expansive area in the left mandible 
extending from the alveolar ridge 
to the base of the mandible in the 
molar region was observed.
Fig. 2. CT axial cut with bone 
window: expansive area of 
heterogeneous density in the 
left mandible.
Fig. 3. Three-dimensional 
reconstruction in CT scan: an 
expansive area in the anterior 
mandible, nasal floor, left side of 
the jaw and frontoparietal suture 
was observed.
Fig. 4. CT axial cut with bone 
window:  expansive area of 
heterogeneous density in the 
anterior mandible. 
Fig. 5. Three-dimensional 
reconstruction in CT scan: 
expansive area in the right 
frontoparietal suture. 
Fig. 6. CT axial scan: 
areas of heterogeneous bone 
expansion in the right and left 
frontoparietal suture. 
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The clinical and histopathological characteristics of 
the lesion, in association with PHT hormone high serum 
levels (1,554 pg/mL with a 16 to 18 pg/mL reference range) 
contributed to renal osteodystrophy diagnosis.
The patient was referred to the nephrology service, 
where she was already being monitored, for medical 
procedures. After the attempted regulation of secondary 
hyperparathyroidism to renal disease through medication, 
a surgical procedure for the removal of the hyperplastic 
parathyroid glands was performed, and healthy fragments 
were implanted in the right upper limb so as to preserve the 
glandular function. 
The regression of the patient’s facial lesions is currently 
being monitored and, in case it is not aesthetically favorable 
enough, repair bone surgery will be proposed to improve the 
patient’s aesthetic facial condition.
Discussion
According to Proctor et al. (8) CRI can generate a wide 
range of oral-facial and dental manifestations, such as 
gingival hyperplasia, periodontal disease, xerostomia, lichen 
planus, uremic stomatitis, candidiasis, herpes simplex, 
delayed dental eruption, enamel hypoplasia, dental mobility 
and renal osteodystroph. In this study, the patient had CRI, 
having only developed periodontal disease and high bone 
remodeling osteodystrophy (osteitis fibrosa) type as oral 
manifestations.
Diagnosis of the specific osteodystrophy type is a rather 
complex process (9), and various biochemical markers and 
radiographic findings are used so as to facilitate this stage. 
However, a sensitive, specific non-invasive method that is 
able to identify the specific osteodystrophic disease is not yet 
available (5). Serum PTH and alkaline phosphatase levels 
are the most commonly used blood tests for this purpose (5), 
their usefulness is, however, questionable (10). In the 
clinical case reported, the blood test evaluation contributed 
to osteitis fibrosa diagnosis, when a high PTH serum 
level (1.554 pg/mL) was observed, suggesting secondary 
hyperparathyroidism.
Due to the low sensitivity of blood analyses, the most 
important exam in the identification of the severity and nature 
of bone disease is still biopsy (5, 10). The histopathological 
analysis identified dense connective tissue permeated by 
inflammatory cells and hemosiderin pigments, in agreement 
with the histopathological findings for  osteitis fibrosa 
diagnosis as described by Hata et al. (11) (Fig. 7).
To reach a diagnosis of bone lesion caused by renal 
osteodystrophy, a differential diagnosis between fibrous 
dysplasia, Paget’s disease (9) and brown tumor (12) must 
be made. The most important factors to distinguish a renal 
osteodystrophy lesion from other bone lesions are the report 
of chronic kidney disease, hemodialysis (9) and secondary 
hyperparathyroidism, once the brown tumor is more likely 
to occur in primary hyperparathyroidism (12) and shows a 
faster growth (13). In 2007, Damm et al. (4) stated that every 
expansive fibrous-osseous lesion in the maxillary bones of 
patients with CRI must be considered an osteodystrophic 
lesion until proven otherwise. In this study, the patient had 
had renal insufficiency for over ten years, and had been 
doing arteriovenous fistula hemodialysis three times a week 
both in the period that preceded the kidney transplantion and 
after the loss of the transplanted organ; the patient had also 
developed secondary hyperparathyroidism. These factors, 
along with the histological analysis, were important for 
establishing the renal osteodystrophy diagnosis.
The most common type of osteodystrophy is osteitis 
fibrosa, which affects about 30 % of the patients with chronic 
renal disease (2,10). Its most usual complications include 
osteopenia and bone fractures (6), affecting mainly long 
bones, ribs and the pelvis; it also affects the maxillary bones 
relatively frequently, which can be a sign of the onset of 
the disease (14). The most common maxillary radiographic 
findings include changes in trabecular bone pattern, a diffuse 
frosted glass appearance, and loss of lamina dura (9). As to the 
case discussed, there had been no history of bone fractures or 
long bone affection. However, dental examination revealed 
bone pattern alterations in the maxilla, mandible and frontal 
bone areas, in agreement with the findings of Kalivas 
et al. (9) who reported frosted glass bone characteristics and 
trabecular bone changes.
A brief review of osteitis fibrosa clinical cases in literature 
reveals the description of similar characteristics, such as the 
slow progression of bone lesions, high parathyroid hormone 
levels, a long hemodialysis history, histopathological findings, 
trabecular bone interspersed with fibrous connective tissue, 
the expansive and painless character of the lesions, and 
treatment based on secondary hyperparathyroidism control, 
mainly by means of parathyroidectomy (9,14,15). The case 
reported in this study presented similar characteristics.
High modeling bone disease treatment is based on the 
control of hyperparathyroidism secondary to the renal 
disease, performed by drug administration or by parathyroid 
removal (7). In this case report, due to the development 
of important bone lesions and the low response to the 
drug therapy used in calcemia and hyperparathyroidism 
control, the patient was submitted to parathyroidectomy 
with parathyroid fragment implant in the right upper limb. 
After the mineral and hormone serum levels related to bone 
metabolism have been corrected, the patient is presently 
undergoing dental treatment to follow the regression of the 
lesions and, if this alone is aesthetically insufficient, she 
may be referred to bone repair surgery, similarly to a case 
reported by Neves et al. (7).
Conclusions
From the clinical case under discussion, it may be 
concluded that bone alterations related to chronic renal 
insufficiency have a high prevalence rate in this population; 
for diagnosis, the professional must take into account 
the possibility of lesions related to bone metabolism 
altered by CRI, such as the different osteodistrophy types, 
without, however, disregarding the possibility of other 
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neoplastic and / or inflammatory pathologies these lesions 
can mimic.
It is important that the dentist should be informed of any 
systemic diseases of the patient; the professional should as 
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well know how to identify the interference of the drugs and 
treatments to control them. Only then will the dentist be 
able to perform the correct diagnosis and propose the most 
adequate treatment for the patient.
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